AlphaMissense, a tool by DeepMind, can help researchers learn more about the effects that missense mutations have on disease, and could help identify previously unknown disease-causing genes, according to a new Science study. Learn more: scim.ag/49l

What If We Could End Incurable Cancers Once And For All? 🚀Exclusive LinkedIn Live event featuring the brilliant Dr. Violet Zahedi, physician & cofounder-CEO of Synamics Therapeutics! 🌐Date: 29 September 2023 🕒Time: 1 pm - 2 pm (Paris Time Zone) 👉linkedin.com/events/whatifw…

A pleasure to be interviewed by the dearest Ari and talk about our focus on intractable #cancer and our mission at Synamics Therapeutics. #aidrugdiscovery #precisiononcology linkedin.com/company/synami… synamics.com

Real #growth happens outside your comfort zone. What’s one bold #challenge you’re ready to take on in 2025? #GrowthMindset #LeadershipDevelopment #PersonalGrowth

Is Pharma's Next Big Leap a Trillion-Dollar Opportunity? linkedin.com/pulse/beyond-a… via LinkedIn

When they say you’re too ambitious... Don’t limit your goals! It’s not a signal to scale your ideas down to fit into what’s understandable or easily achievable. If it were easy, someone else would have done it already. The world doesn’t change with small ideas! #thinkbig